ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
67,702.22
0.33%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Orgenesis Inc (ORGS)

  7. Orgenesis Inc (ORGS) 뉴스

ORGS

Orgenesis (ORGS)

Orgenesis Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ORGS
일자시간출처헤드라인심볼기업
2024/05/3119:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
2024/05/2422:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ORGSOrgenesis Inc
2024/05/2321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
2024/05/2120:00GlobeNewswire Inc.Orgenesis Provides Business Update for the First Quarter of 2024NASDAQ:ORGSOrgenesis Inc
2024/05/2105:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
2024/05/1605:01Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ORGSOrgenesis Inc
2024/05/0704:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORGSOrgenesis Inc
2024/05/0704:28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ORGSOrgenesis Inc
2024/05/0704:26Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORGSOrgenesis Inc
2024/04/1606:07GlobeNewswire Inc.Orgenesis Provides Year End Business UpdateNASDAQ:ORGSOrgenesis Inc
2024/04/1101:00GlobeNewswire Inc.Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global AccessibilityNASDAQ:ORGSOrgenesis Inc
2024/03/1821:30GlobeNewswire Inc.Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe ConferenceNASDAQ:ORGSOrgenesis Inc
2024/03/1321:30GlobeNewswire Inc.Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic ExosomesNASDAQ:ORGSOrgenesis Inc
2024/03/0422:30GlobeNewswire Inc.Orgenesis Inc. Announces $2.3 Million Private PlacementNASDAQ:ORGSOrgenesis Inc
2024/02/2922:30GlobeNewswire Inc.Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP ManufacturingNASDAQ:ORGSOrgenesis Inc
2024/01/3123:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
2024/01/3123:15GlobeNewswire Inc.Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to ClinicNASDAQ:ORGSOrgenesis Inc
2024/01/2506:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
2024/01/2306:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
2024/01/0907:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
2024/01/0907:36Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
2024/01/0520:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
2023/11/1422:30GlobeNewswire Inc.Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TMNASDAQ:ORGSOrgenesis Inc
2023/11/1406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
2023/11/1406:15GlobeNewswire Inc.Orgenesis Provides Business Update for the Third Quarter of 2023NASDAQ:ORGSOrgenesis Inc
2023/11/0921:41Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ORGSOrgenesis Inc
2023/11/0823:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
2023/11/0823:00GlobeNewswire Inc.Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct OfferingNASDAQ:ORGSOrgenesis Inc
2023/11/0221:00GlobeNewswire Inc.Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant FundingNASDAQ:ORGSOrgenesis Inc
2023/10/3110:30GlobeNewswire Inc.Orgenesis Announces Withdrawal of Proposed Public OfferingNASDAQ:ORGSOrgenesis Inc
 검색 관련기사 보기:NASDAQ:ORGS

최근 히스토리

AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
SPI
SP500
S&P 500
NYSE
CVX
Chevron
AMEX
SPY
SPDR S&P 500
FX
USDJPY
US Dollar vs Yen
NYSE
XOM
Exxon Mobil
NYSE
AXP
American Express
AMEX
XLF
Financial Select Sector
COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
USOTC
RHHBY
Roche (QX)
CCOM
US100
US Tech 100
NASDAQ
AMZN
Amazon.com
FX
USDGBP
US Dollar vs Sterling
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유